Patents Assigned to Providence Health System
-
Patent number: 8652836Abstract: Methods are disclosed for producing defective ribosomal products (DRiPs) in blebs (DRibbles) by contacting cells with a proteasome inhibitor, and in some examples also an autophagy inducer, thereby producing treated cells. DRibbles can be used to load antigen presenting cells (APCs), thereby allowing the APCs to present the DRiPs and antigenic fragments thereof. Immunogenic compositions that include treated cells, isolated DRibbles, or DRibble-loaded APCs are also disclosed. Methods are also provided for using treated cells, isolated DRibbles, or DRibble-loaded APCs to stimulate an immune response, for example in a subject. For example, DRibbles obtained from a tumor cell can be used to stimulate an immune response against the same type of tumor cells in the subject. In another example, DRibbles obtained from a pathogen-infected cell or cell engineered to express one or more antigens of a pathogen can be used to stimulate an immune response against the pathogen in the subject.Type: GrantFiled: July 27, 2006Date of Patent: February 18, 2014Assignee: Providence Health SystemInventor: Hong-Ming Hu
-
Publication number: 20110274726Abstract: The invention provides a solid foam wound dressing useful for hemorrhage control and wound repair, as well as methods for making such a wound dressing.Type: ApplicationFiled: October 6, 2009Publication date: November 10, 2011Applicant: PROVIDENCE HEALTH SYSTEM - OREGONInventors: Jian Xin Guo, Kenton W. Gregory
-
Patent number: 7959925Abstract: Compositions including a trimeric OX-40 fusion protein are disclosed. Also disclosed are methods for enhancing the immune response of a mammal to an antigen by engaging the OX-40 receptor on the surface of T-cells involving administering to the mammal a composition comprising a trimeric OX-40 fusion protein and a pharmaceutically acceptable carrier.Type: GrantFiled: November 13, 2009Date of Patent: June 14, 2011Assignee: Providence Health SystemInventors: Andrew D. Weinberg, Nicholas P. Morris, Carmen Romerdaue
-
Patent number: 7820872Abstract: A chitosan biomaterial is frozen in aqueous solution to form a frozen chitosan structure from which water is removed by a prescribed freeze-drying process to form a sponge-like chitosan structure having a thickness and a density. The sponge-like chitosan structure is compressed by application of heat and pressure to reduce the thickness and increase the density of the sponge-like chitosan structure to form a densified chitosan structure. The densified chitosan structure is further preconditioned by heating the densified chitosan structure according to prescribed conditions to form a wound dressing. The wound dressing possesses an adhesion strength and resistance to dissolution in high blood flow bleeding situations.Type: GrantFiled: October 31, 2007Date of Patent: October 26, 2010Assignee: Providence Health System-OregonInventors: Kenton W Gregory, Simon McCarthy
-
Publication number: 20090192825Abstract: A process and/or system that extracts selected information from e.g. traditional electronics medical records to enable analysis of a determined medical condition shared by multiple patients. A data warehouse receives the extracted information and reformats that information to enable rapid analysis by a health care provider of that provider's patient population having that medical condition. It further collects the selective data of the selected patients for multiple health care providers and enables comparisons of health care providers' success for such patients to promote upgrading of the treatment by less successful providers.Type: ApplicationFiled: March 12, 2009Publication date: July 30, 2009Applicant: Providence Medical Group, a Division of Providence Health System-OregonInventors: Jacquelyn Suzanne Hunt, Joseph Siemienczuk
-
Publication number: 20090169593Abstract: A device implantable within a human body, and a method for producing the device, are provided. The device comprises a biocompatible coating on at least a portion of an outer surface of a substrate. The biocompatible coating comprises tropoelastin. A biocompatible coating is formed in situ on the outer surface of the substrate.Type: ApplicationFiled: October 19, 2006Publication date: July 2, 2009Applicants: BIOMEDICAL RESEARCH SERVICES, INC., PROVIDENCE HEALTH SYSTEMS - Oregon, an Oregon Nonprofit CorporationInventors: Kenton W. Gregory, Robert Glanville, Hooi-Sung Kim, Rui-Qing Qian, Carl Wamser
-
Publication number: 20090164248Abstract: A patient management system, comprising of a care provider interface, configured to receive a selection of a plurality of patients and a data processing system configured to signal whether to exclude an individual patient within a subset of the plurality of patients based on an intervention parameter and further configured to send a communication to each of the patients in the subset.Type: ApplicationFiled: December 21, 2007Publication date: June 25, 2009Applicant: PROVIDENCE MEDICAL GROUP, A DIVISION OF PROVIDENCE HEALTH SYSTEMInventors: Jacquelyn Suzanne Hunt, Joseph Siemienczuk
-
Publication number: 20090164237Abstract: A patient management system, comprising of a care provider interface, configured to receive a selection of a plurality of individual patients and a data processing system, configured to automatically generate a plurality of personalized patient-specific communications based on the selection, the communication directed to individual selected patients, each patient communication including at least one personalized patient care parameter specific to the individual selected patient.Type: ApplicationFiled: December 21, 2007Publication date: June 25, 2009Applicant: PROVIDENCE MEDICAL GROUP, a Division of Providence Health System - OregonInventors: Jacquelyn Suzanne Hunt, Joseph Siemienczuk
-
Publication number: 20090164249Abstract: A customizable patient management system, comprising of a patient database including a plurality of patient specific care parameters, a user-interface to select a one or more patient specific care parameters for sorting the patient database, and a data processing system, configured to sort the patient database based on the selected care parameters and display a set of patients corresponding to the selected care parameters where the set of patients may be at risk for or have a common health condition.Type: ApplicationFiled: December 21, 2007Publication date: June 25, 2009Applicant: PROVIDENCE MEDICAL GROUP, A DIVISION OF PROVIDENCE HEALTH SYSTEM - OREGONInventors: Jacquelyn Suzanne Hunt, Joseph Siemienczuk
-
Patent number: 7523042Abstract: A process and/or system that extracts selected information from e.g. traditional electronics medical records to enable analysis of a determined medical condition shared by multiple patients. A data warehouse receives the extracted information and reformats that information to enable rapid analysis by a health care provider of that provider's patient population having that medical condition. It further collects the selective data of the selected patients for multiple health care providers and enables comparisons of health care providers' success for such patients to promote upgrading of the treatment by less successful providers.Type: GrantFiled: January 17, 2003Date of Patent: April 21, 2009Assignee: Providence Medical Group, a division of Providence Health System - OregonInventors: Jacquelyn Suzanne Hunt, Joseph Siemienczuk
-
Patent number: 7482503Abstract: This invention is directed to advanced hemorrhage control wound dressings, and methods of using a producing same. The subject wound dressing is constructed from a non-mammalian material for control of severe bleeding. The wound dressing is formed of a biomaterial comprising chitosan for controlling severe bleeding. The kind of severe, life-threatening bleeding contemplated by this invention is typically of the type not capable of being stanched when a conventional gauze wound dressing is applied with conventional pressure to the subject wound. The wound dressing being capable of substantially stanching the flow of the severe life-threatening bleeding from the wound by adhering to the wound site, to seal the wound, to accelerate blood clot formation at the wound site, to reinforce clot information at the wound site and prevent bleed out from the wound site, and to substantially prohibit the flow of blood out of the wound site.Type: GrantFiled: June 14, 2002Date of Patent: January 27, 2009Assignees: Providence Health System-OregonInventors: Kenton W Gregory, Simon McCarthy
-
Patent number: 7371403Abstract: This invention is directed to advanced hemorrhage control wound dressings, and methods of using and producing same. The subject wound dressing is constructed from a non-mammalian material for control of severe bleeding. The wound dressing for controlling severe bleeding is formed of a biomaterial comprising chitosan, a hydrophilic polymer, a polyacrylic polymer or a combination thereof. The kind of severe, life-threatening bleeding contemplated by this invention is typically of the type not capable of being stanched when a conventional gauze wound dressing is applied with conventional pressure to the subject wound. The wound dressing being capable of substantially stanching the flow of the severe life-threatening bleeding from the wound by adhering to the wound site, to seal the wound, to accelerate blood clot formation at the wound site, to reinforce clot formation at the wound site and prevent bleed out from the wound site, and to substantially prohibit the flow of blood out of the wound site.Type: GrantFiled: December 23, 2003Date of Patent: May 13, 2008Assignees: Providence Health System-OregonInventors: Simon J. McCarthy, Kenton W. Gregory, William P. Wiesmann, Todd D. Campbell
-
Patent number: 7322932Abstract: A bioprosthetic valve graft comprises a valve frame and valve flaps, the latter acting to open or close a valve aperture to directionally control fluid flow through the bioprosthesis. The bioprosthetic valve graft comprises method for suturelessly attaching a biomaterial suturelessly bonded to the A method for securing a biomaterial to a valve frame includes positioning a flexible valve frame defining an open area on a first major surface of a biomaterial sheet having a peripheral edge, wherein positioning serves to approximate the valve frame and the peripheral edge of the biomaterial sheet to form an at least first bonding locus; and suturelessly bonding the biomaterial to the valve frame at the at least first bonding locus. The method avoids the disadvantages associated with conventional sutures and substantially reduces medical complications in implantations.Type: GrantFiled: February 2, 2004Date of Patent: January 29, 2008Assignee: Providence Health System - OregonInventors: Hua Xie, Lisa A. Buckley
-
Patent number: 7166124Abstract: A bioprosthetic stent graft is disclosed, having a stent frame and a biomaterial sheath suturelessly bonded to the stent frame. Sutureless bonding avoids sutures and substantially reducing medical complications in implantation of the stent graft. A device and method for manufacturing the stent graft further is disclosed. A mandrel is employed for shaping the stent graft, and means for irradiating the biomaterial effects sutureless bonding.Type: GrantFiled: March 21, 2002Date of Patent: January 23, 2007Assignee: Providence Health System - OregonInventors: Hua Xie, Lisa A. Buckley
-
Patent number: 7163556Abstract: A bioprosthetic valve graft comprises a valve frame and valve flaps, the latter acting to open or close a valve aperture to directionally control fluid flow through the bioprosthesis. The bioprosthetic valve graft comprises a biomaterial suturelessly bonded to the valve frame, avoiding sutures and substantially reducing medical complications in implantations.Type: GrantFiled: March 21, 2002Date of Patent: January 16, 2007Assignee: Providence Health System - OregonInventors: Hua Xie, Lisa A. Buckley
-
Patent number: 7088455Abstract: Methods for measuring strains in biological and other samples include illuminating a specimen with substantially collimated laser flux. An electro-acoustic transducer is activated to generate acoustic waves in the specimen, including a surface wave component such as a Rayleigh wave. A series of laser speckle patterns produced by a laser flux scattered or reflected by the specimen is recorded and speckle pattern shifts are calculated based on the recorded speckle patterns. Phase shifts produced by acoustic wave propagation in the specimen are used to identify specimen regions associated with irregularities such as inclusions, cracks, or tissue abnormalities. In some examples, specimens are stretched or otherwise stressed by one or more light fluxes, and specimen elongation is estimated based on a series of associated speckle patterns.Type: GrantFiled: June 14, 2002Date of Patent: August 8, 2006Assignee: Providence Health Systems —OregonInventors: Sean J. Kirkpatrick, Donald D. Duncan
-
Patent number: 7079257Abstract: Methods for measuring strains in circuit substrates such as circuit boards and semiconductor wafers include illuminating a specimen with a substantially collimated laser flux. A temperature change is produced in the specimen and a series of laser speckle patterns produced by a laser flux scattered or reflected by the specimen is recorded. Localized strains are detected based on speckle pattern shifts that are calculated using the recorded speckle patterns. Stains can be recorded as a function of temperature or rate of change of temperature, and strains at one or more circuit substrate locations can be detected.Type: GrantFiled: April 15, 2003Date of Patent: July 18, 2006Assignee: Providence Health SystemInventors: Sean J. Kirkpatrick, Donald D. Duncan
-
Patent number: 7001328Abstract: It is a general object of the invention to provide a method of effecting repair or replacement or supporting a section of a body tissue using tropoelastin, preferably crosslinked tropoelastin and specifically to provide a tropoelastin biomaterial suitable for use as a stent, for example, a vascular stent, or as conduit replacement, as an artery, vein or a ureter replacement. The tropoelastin biomaterial itself can also be used as a stent or conduit covering or coating or lining.Type: GrantFiled: February 7, 1997Date of Patent: February 21, 2006Assignees: Providence Health Systems-OregonInventors: Andrew D. Barofsky, Kenton W. Gregory
-
Patent number: 6896809Abstract: One method for purifying a chitosan starting material includes contacting it with at least one treatment agent selected from a protein-complexing agent, a metal-chelating agent, and a metal-complexing agent under pH conditions effective for forming a water insoluble chitosan precipitate and at least one water soluble material selected from a water soluble protein complex, a water soluble metal chelate, and a water soluble metal complex. Another variant involves solubilizing the chitosan starting material in an aqueous solution to produce an intermediate chitosan material. The intermediate chitosan material is contacted with a deproteinization agent and/or a demetallization agent under pH conditions effective for forming a water insoluble chitosan precipitate and at least one water soluble material that includes the pre-existing impurity. In both methods, the water insoluble chitosan precipitate and the water soluble material are separated resulting in a purified chitosan material.Type: GrantFiled: December 20, 2002Date of Patent: May 24, 2005Assignee: Providence Health System - OregonInventors: Rui Qing Qian, Robert W. Glanville
-
Patent number: RE43134Abstract: The present invention provides a denatured albumin lamina, useful for repairing lesions on solid visceral organs. The lamina comprises human serum albumin, formed into a thin, pliant sheet and denatured. The denatured lamina can be sterilized and stored until used. As well, it can be impregnated with a variety of bioagents. A method for repairing a lesion on a solid visceral organ includes applying an energy-absorbing proteinaceous material to a lesion site on the solid visceral organ lesion; irradiating the proteinaceous material with energy sufficient to fuse the energy-absorbing material at least partially to the lesion site; applying a biocompatible denatured albumin lamina onto the proteinaceous material on the lesion site; and irradiating the biocompatible albumin lamina and the proteinaceous material with energy sufficient to fuse the biocompatible albumin lamina to the proteinaceous material and/or the lesion site.Type: GrantFiled: April 8, 2005Date of Patent: January 24, 2012Assignee: Providence Health System - OregonInventors: Yasmin Wadia, Scott Alan Prahl